Saturday 17 October 2026
Export CL’s income statement to Excel — free account
Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024. In the quarter to June 2026, revenue grew 4.91%, EPS fell 5.43%, free cash flow grew 11.7% and total debt fell 10.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five, operating cash flow growth for three.
94.11
1.44
+1.55%
Follow CL
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 61.40 | 63.43 | 57.41 | 58.62 | 58.49 | 74.01 | 67.84 | 67.62 | 79.39 | 74.55 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 75.38 | 77.27 | 77.91 | 76.41 | 86.41 | 85.56 | 85.61 | 82.09 | 109.30 | 100.18 | |||||
| People | |||||||||||||||
| People | Employees | 36,700 | 35,900 | 34,500 | 34,300 | 34,200 | 33,800 | 33,800 | 34,000 | 34,000 | 33,600 | ||||
| Revenue/emp, $m | 0.41 | 0.43 | 0.45 | 0.46 | 0.48 | 0.52 | 0.53 | 0.57 | 0.59 | 0.61 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 15,195 | 15,454 | 15,544 | 15,693 | 16,471 | 17,421 | 17,967 | 19,457 | 20,101 | 20,382 | ||||
| Gross margin, % | 60.04 | 60.05 | 59.39 | 59.42 | 60.82 | 59.55 | 57.04 | 58.21 | 60.50 | 60.11 | |||||
| EBT | 3,738 | 3,487 | 3,464 | 3,301 | 3,647 | 3,087 | 2,660 | 3,392 | 3,956 | 3,059 | |||||
| EBT margin, % | 24.60 | 22.56 | 22.29 | 21.03 | 22.14 | 17.72 | 14.80 | 17.43 | 19.68 | 15.01 | |||||
| Net income | 2,586 | 2,174 | 2,558 | 2,527 | 2,860 | 2,338 | 1,967 | 2,455 | 3,049 | 2,261 | |||||
| Depreciation | 443 | 475 | 511 | 519 | 539 | 1,127 | 1,266 | 567 | 605 | 1,549 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 17.04 | 17.53 | 17.85 | 18.27 | 19.22 | 20.62 | 21.48 | 23.52 | 24.54 | 25.20 | ||||
| Earnings | 2.74 | 2.30 | 2.76 | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 | 3.53 | 2.64 | |||||
| Cash flow | 3.52 | 3.46 | 3.51 | 3.65 | 4.34 | 3.93 | 3.06 | 4.53 | 5.01 | 5.19 | |||||
| Capex | (0.60) | (0.58) | (0.50) | (0.39) | (0.48) | (0.67) | (0.78) | (0.85) | (0.68) | (0.70) | |||||
| Free cash flow | 2.92 | 2.89 | 3.01 | 3.26 | 3.86 | 3.26 | 2.28 | 3.67 | 4.33 | 4.49 | |||||
| Book value | 0.02 | 0.28 | 0.23 | 0.65 | 1.29 | 1.15 | 0.96 | 1.16 | 0.66 | 0.45 | |||||
| Shares, m | 892 | 882 | 871 | 859 | 857 | 845 | 836 | 827 | 819 | 809 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 23.92 | 32.81 | 21.64 | 25.03 | 27.23 | 33.34 | 36.98 | 28.93 | 25.75 | 30.05 | ||||
| P/S | 3.85 | 4.29 | 3.33 | 3.77 | 4.45 | 4.14 | 3.68 | 3.43 | 3.70 | 3.14 | |||||
| P/B | 3,438.15 | 272.67 | 263.04 | 105.99 | 66.54 | 74.27 | 82.11 | 69.79 | 136.88 | 175.08 | |||||
| EV/Sales | 4.25 | 4.67 | 3.75 | 4.20 | 4.84 | 4.51 | 4.13 | 3.82 | 4.05 | 3.46 | |||||
| EV/FCF | 24.75 | 28.37 | 22.27 | 23.53 | 24.09 | 28.46 | 38.89 | 24.46 | 22.93 | 19.43 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 3,141 | 3,054 | 3,056 | 3,133 | 3,719 | 3,325 | 2,556 | 3,745 | 4,107 | 4,198 | ||||
| Capex | (533) | (509) | (436) | (335) | (410) | (567) | (649) | (705) | (561) | (564) | |||||
| Free cash flow | 2,608 | 2,545 | 2,620 | 2,798 | 3,309 | 2,758 | 1,907 | 3,040 | 3,546 | 3,634 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 1,033 | 1,231 | 452 | 141 | (66) | 346 | 1,109 | 538 | (442) | (1,144) | ||||
| Total debt | 6,533 | 6,577 | 6,366 | 7,587 | 7,343 | 7,206 | 8,755 | 8,549 | 7,949 | 7,988 | |||||
| Net debt | 5,218 | 5,042 | 5,640 | 6,704 | 6,455 | 6,374 | 7,980 | 7,583 | 6,853 | 6,700 | |||||
| Shareholders’ equity | 17 | 243 | 197 | 558 | 1,101 | 971 | 806 | 957 | 544 | 365 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 20.29 | 16.32 | 19.33 | 17.41 | 17.41 | 13.99 | 11.60 | 14.32 | 17.81 | 13.17 | ||||
| ROIC | 47.22 | 43.84 | 39.55 | 30.59 | 32.14 | 28.35 | 20.58 | 29.16 | 36.06 | 29.25 | |||||
| ROE | (18,081.48) | 1,556.92 | 1,090.91 | 627.02 | 324.89 | 209.07 | 200.90 | 260.92 | 384.94 | 469.09 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Colgate-Palmolive Company vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| PG Procter & Gamble Company (The) | $364.9B | 23.5× | 20.9× | +1.50% (above 0%: growing) | −15.23% (below 0%: shrinking) | +2.06% (above 0%: growing) | 48.50% | 18.62% | Compare |
| UL Unilever PLC | $139.3B | 11.2× | — | +8.58% (above 0%: growing) | +8.84% (above 0%: growing) | −19.66% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| CL Colgate-Palmolive Company | $73.9B | 37.1× | 23.9× | +4.91% (above 0%: growing) | −5.43% (below 0%: shrinking) | +11.73% (above 0%: growing) | 61.48% | 18.95% | |
| EL The Estee Lauder Companies Inc. | $38.8B | 205× | 28.0× | +6.33% (above 0%: growing) | n/m | +7.87% (above 0%: growing) | 75.46% | (1.08%) | Compare |
| KVUE Kenvue Inc. | $35.9B | 21.7× | 18.6× | +3.02% (above 0%: growing) | +9.09% (above 0%: growing) | +17.07% (above 0%: growing) | 58.18% | 17.67% | Compare |
| KMB Kimberly-Clark Corporation | $34.6B | 18.0× | 14.4× | +0.62% (above 0%: growing) | −32.03% (below 0%: shrinking) | −4.79% (below 0%: shrinking) | 38.27% | 15.11% | Compare |
| CHD Church & Dwight Co., Inc. | $24.5B | 33.5× | 26.3× | +1.57% (above 0%: growing) | +10.26% (above 0%: growing) | +23.33% (above 0%: growing) | 45.35% | 18.07% | Compare |
| CLX The Clorox Company | $10.4B | 18.1× | 14.8× | −2.01% (below 0%: shrinking) | −50.37% (below 0%: shrinking) | +11.42% (above 0%: growing) | 41.27% | 13.24% | Compare |
| ELF e.l.f. Beauty | $6.9B | 113× | 21.2× | +35.52% (above 0%: growing) | +91.53% (above 0%: growing) | +447.39% (above 0%: growing) | 83.20% | 21.37% | Compare |
| Median of peers | $35.2B | 22.6× | 20.9× | +2.29% | +8.84% | +9.65% | 46.93% | 16.39% |
CL metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
Colgate-Palmolive Company (CL) key facts
- Concern: Net income was $2.3 billion, or $2.64 per share (basic), a net margin of 10.5%.
- Strength: Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Colgate-Palmolive Company (CL) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- As of October 16, 2026, CL traded at $94.11, a market capitalization of $73.9 billion.
- At that price the stock trades at 37.1× trailing-twelve-month earnings and 3.6× sales; its P/E is higher than 84% of its own readings over the past ten years.
- Colgate-Palmolive Company pays an annual dividend of $2.63 per share, a yield of 2.79%, with a payout ratio of 104.4%.
- Return on equity was 469.1% and debt-to-equity 13.88.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 6.51 (safe zone) for fiscal 2025.